Prokidney (PROK) Accumulated Expenses (2021 - 2026)

Prokidney (PROK) has reported Accumulated Expenses for 6 consecutive years, with $20.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Accumulated Expenses fell 19.85% year-over-year to $20.0 million in Q2 2026; TTM through Jun 2026 was $20.0 million, a 19.85% decrease from a year earlier, with the FY2025 full-year figure at $28.7 million, down 7.73% from the prior year.
• Accumulated Expenses was $20.0 million for Q2 2026 at Prokidney, down from $22.2 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $31.1 million in Q4 2024 and troughed at $5.3 million in Q1 2022.
• A 5-year average of $17.6 million and a median of $18.8 million in 2023 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses surged 8639715.91% in 2022 and dropped 27.86% in 2024, its largest moves.
• Over 5 years, Accumulated Expenses stood at $7.3 million in 2022, then soared by 140.8% to $17.7 million in 2023, then jumped by 76.26% to $31.1 million in 2024, then slipped by 7.73% to $28.7 million in 2025, then slumped by 30.49% to $20.0 million in 2026.
• The last three Accumulated Expenses figures came in at $20.0 million (Q2 2026), $22.2 million (Q1 2026), and $28.7 million (Q4 2025), per Business Quant data.